BWAY | BrainsWay Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	8.82 - 9.35
52 Week Range	4.61 - 10.98
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	51,532
Average Volume	90,290
Shares Outstanding	18,813,200
Market Cap	173,833,968
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2019-04-17

Valuation
Profitability
Growth
Health
P/E Ratio	115.50
Forward P/E Ratio	N/A
EPS	0.08
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	134
Country	Israel
Website	BWAY

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

BWAY's peers: MDGS, DCTH, HSKA, FNA, USAQ, VAPO, VERO, TCMD, NPCE, ELMD, KIDS, SRDX, CVRX, OFIX, AORT, AZYO, AIMD, LNSR, IRIX, ICCM

*Chart delayed

Analyzing fundamentals for BWAY we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is good and Health is weak. For more detailed analysis please see BWAY Fundamentals page.

Watching at BWAY technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on BWAY Technicals page.